[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
Chi NF, Wang SJ. CYP2C19 loss-of-function alleles: a common but overlooked problem associated with clopidogrel resistance[J]. J Chin Med Assoc, 2019, 82(10): 746-747. DOI: 10.1097/JCMA.0000000000000168.
|
[7] |
|
[8] |
|
[9] |
Ye Z, Hu J, Xu H, et al. Serum exosomal microRNA-27-3p aggravates cerebral injury and inflammation in patients with acute cerebral infarction by targeting PPARγ[J]. Inflammation, 2021, 44(3): 1035-1048. DOI: 10.1007/s10753-020-01399-3.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
El-Khodary NM, El-Behery AM, El-Askary NA, et al. The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease[J]. Eur Rev Med Pharmacol Sci, 2021, 25(19): 6065-6076.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|